CHAD's 3rd quarter earnings drop off
By HME News Staff
Updated Sun December 31, 2006
CHATSWORTH, Calif. - CHAD Therapeutics posted revenues of $4.98 million in revenues for the quarter ended Sept. 30, 2006, compared to revenues of $5.4 million for the same quarter in 2005, the company stated in October. Sales of CHAD's Total O2 home oxygen filling system dropped 29% for the six months ended Sept. 20, 2006, compared to the same period last year. Therapeutic devices dropped 4% compared to last year.
Comments